Denmark· DK-28103474703
Mianserin "Orifarm"
A mianserin product containing mianserinhydrochlorid, registered in Denmark by Orifarm Generics A/S. The same ATC class is registered in 15 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Mianserin is registered in 15 of 19 countries.
Countries holding a registration under ATC N06AX03 (mianserin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Mianserin · ATC N06AX03
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of mianserin costs, country by country.
Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.32 in France to $1.15 in Switzerland — a ×3.6 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mianserin · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.15
- IT Italy$0.68
- FR France$0.32
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- MIANSERINHYDROCHLORID
- Manufacturer
- Orifarm Generics A/S
- Country
- Denmark (DK)
- ATC code
- N06AX03
- ATC class
- Mianserin
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28103474703
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
19 interactions on record for mianserin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mianserin · interactions on record
19 records
19 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under N06AX03
Mianserin, as other registers publish it.
- PolandDeprexoletAdamed Pharma S.A.
- PolandDeprexoletAdamed Pharma S.A.
- PolandDeprexoletAdamed Pharma S.A.
- ItalyLANTANON*30 cpr rivestite 30 mgORGANON ITALIA Srl
- PolandLerivonOrganon Polska Sp. z o.o.
- PolandLerivonOrganon Polska Sp. z o.o.
- CzechiaLERIVONMerck Sharp & Dohme B.V., Haarlem
- CzechiaLERIVONN.V. Organon, Oss
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cdea0d1c-87c4-4373-b6b3-341a734528e5 GET /v1/drugs/cdea0d1c-87c4-4373-b6b3-341a734528e5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "30 mg",
"auth_role": "DKMA",
"dk_drugid": "28103474703",
"substance": "MIANSERINHYDROCHLORID",
"auth_procedure": "National",
"in_medicinpriser": false,
"registration_date_serial": "38534"
}See everything about mianserin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.